Scarica l'app Stockscreener
0.7662
15.01%
0.10
Dopo l'orario di chiusura:
.75
-0.0162
-2.11%
Precedente Chiudi:
$0.6662
Aprire:
$0.7
Volume 24 ore:
3.40M
Relative Volume:
0.76
Capitalizzazione di mercato:
$50.48M
Reddito:
-
Utile/perdita netta:
$-86.08M
Rapporto P/E:
-0.3551
EPS:
-2.1574
Flusso di cassa netto:
$-72.06M
1 W Prestazione:
+44.73%
1M Prestazione:
-55.45%
6M Prestazione:
-13.91%
1 anno Prestazione:
-35.61%
Intervallo 1D:
$0.6344
$0.7664
Intervallo di 1 settimana:
$0.55
$0.7664
Portata 52W:
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
Nome
Io Biotech Inc
Settore
Industria
Telefono
(457) 070-2980
Indirizzo
OLE MAALOES VEH 3, COPENHAGEN
Confronta IOBT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.7662 | 42.28M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | Downgrade | TD Cowen | Buy → Hold |
Io Biotech Inc Borsa (IOBT) Ultime notizie
How hedge fund analytics apply to IO Biotech Inc. stockIPO Watch & Low Drawdown Investment Strategies - newser.com
Is IO Biotech Inc. stock near bottom after decline2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Key resistance and support levels for IO Biotech Inc.July 2025 Momentum & Community Supported Trade Ideas - newser.com
Can momentum traders help lift IO Biotech Inc.Treasury Yields & Fast Gaining Stock Reports - newser.com
Applying chart zones and confluence areas to IO Biotech Inc.Portfolio Gains Report & Risk Controlled Daily Plans - newser.com
Will IO Biotech Inc. stock outperform tech sector in 2025July 2025 PostEarnings & Precise Buy Zone Identification - newser.com
Melanoma Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Has IO Biotech Inc. found a price floorFed Meeting & AI Powered Buy and Sell Recommendations - newser.com
IO Biotech announces up to €57.5M debt financing from the European Investment Bank - MSN
IO Biotech Inc. stock prediction for this weekMarket Volume Report & Weekly High Return Stock Forecasts - newser.com
Layoff Tracker: Ferring To Cut 500 Employees as Part of Business Model Shift - BioSpace
Candlestick signals on IO Biotech Inc. stock today2025 Sector Review & Technical Analysis for Trade Confirmation - newser.com
Does IO Biotech Inc. qualify in momentum factor screeningRisk Management & Verified Technical Signals - newser.com
Multi asset correlation models including IO Biotech Inc.Market Performance Recap & Growth Oriented Trading Recommendations - newser.com
Tick level data insight on IO Biotech Inc. volatilityEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - Sahm
How IO Biotech Inc. stock reacts to global recession fearsEntry Point & Safe Capital Growth Trade Ideas - newser.com
How sentiment analysis helps forecast IO Biotech Inc.Earnings Performance Report & Risk Managed Trade Strategies - newser.com
What does recent volatility data suggest for IO Biotech Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Analysts Set IO Biotech, Inc. (NASDAQ:IOBT) Price Target at $8.00 - Defense World
IO Biotech (NASDAQ:IOBT) Downgraded to Equal Weight Rating by Morgan Stanley - Defense World
IO Biotech’s (IOBT) Hold Rating Reaffirmed at TD Cowen - Defense World
IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne - GuruFocus
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says - MarketScreener
IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes - insights.citeline.com
IO Biotech (NASDAQ:IOBT) Receives "Hold" Rating from TD Cowen - MarketBeat
TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating - 富途牛牛
TD Cowen Downgrades IO Biotech to Hold From Buy - MarketScreener
FDA Recommends Against IO Biotech’s Cylembio Application - The Globe and Mail
Morgan Stanley Downgrades IO Biotech to Equalweight From Overweight, Cuts Price Target to $0.39 From $4 - MarketScreener
Io Biotech Inc Azioni (IOBT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Io Biotech Inc Azioni (IOBT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ahmad Qasim Iftikhar | Chief Medical Officer |
Dec 23 '24 |
Buy |
0.85 |
31,350 |
26,553 |
31,350 |
| Zocca Mai-Britt | Chief Executive Officer |
Dec 23 '24 |
Buy |
0.81 |
12,500 |
10,120 |
49,891 |
| Sullivan Amy | Chief Financial Officer |
Dec 23 '24 |
Buy |
0.83 |
10,250 |
8,483 |
84,632 |
| Smith Devin Whittemore | General Counsel |
Dec 23 '24 |
Buy |
0.81 |
12,000 |
9,720 |
16,938 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):